To the SIO Community,
On behalf of the SIO Board of Directors and staff, I hope this note finds you in good health and good spirits.
I write to you all today to share that SIO is committed to holding a safe, enjoyable Annual Scientific Meeting in San Francisco, 3-7 February 2022.
I would like to open this message with a warm thank you to all the attendees, supporters, organizers, faculty, staff and other volunteers who helped make our SIO2021 Virtual Annual Scientific Meeting a success.
The SIO NCCN Task Force submitted recommendations to the NCCN for the latest revision of the Neuroendocrine Tumor treatment guidelines. Rony Avritscher from MD Anderson Cancer Center, Nick Fidelman from UCSF, and Etay Ziv from Memorial Sloan Kettering Cancer Center authored the SIO submission.
COVID19 poses a real threat to the well-being of our patients and we, as physician-scientists, are taking this threat seriously. In light of the available data, we act diligently to protect those most vulnerable in this situation: our cancer patients. The necessary measures to mitigate the spread of
Cancer care during the pandemic requires assessment of several factors that are specific to each patient as well as the curve of the pandemic in a particular location and the infrastructure capabilities at the center offering care. As a general approach, we consider continuation of cancer care unles